WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Ownership - Who owns Adaptive Biotechnologies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adaptive Biotechnologies Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Harlan S. RobinsChief Scientific Officer2026-02-038,120$19.00
$154.28kSell
Chad M. RobinsCEO and Chairman2026-02-02124,998$18.44
$2.30MSell
Harlan S. RobinsChief Scientific Officer2026-02-0234,668$18.60
$644.82kSell
Francis LoChief People Officer2026-01-1221,002$8.46
$177.68kBuy
Francis LoChief People Officer2026-01-1214,215$3.99
$56.72kBuy
Francis LoChief People Officer2026-01-1279,590$17.73
$1.41MSell
Kyle PiskelChief Financial Officer2026-01-124,290$18.00
$77.22kSell
Kyle PiskelChief Financial Officer2026-01-124,290$12.14
$52.08kBuy
Francis LoChief People Officer2026-01-1236,650$7.80
$285.87kBuy
Francis LoChief People Officer2026-01-127,723$12.14
$93.76kBuy

1 of 10

ADPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADPT insiders and whales buy or sell their stock.

ADPT Shareholders

What type of owners hold Adaptive Biotechnologies Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Performance LLC20.30%30,993,708$536.19MInsider
Viking Global Investors LP19.65%29,993,708$518.89MInsider
Viking Global Investors LP19.65%29,993,708$518.89MInstitution
Blackrock Inc8.75%13,357,977$231.09MInstitution
David E. Goel8.06%12,310,594$212.97MInsider
Vanguard Group Inc7.39%11,275,169$195.06MInstitution
Ameriprise Financial Inc3.91%5,971,706$103.31MInstitution
Chad M. Robins3.86%5,896,745$102.01MInsider
Amova Asset Management Americas Inc2.39%3,650,646$63.16MInstitution
Sumitomo Mitsui Trust Group Inc2.39%3,650,646$63.16MInstitution

1 of 3

ADPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADPT62.25%37.75%Net SellingNet Selling
BEAM86.38%13.62%Net SellingNet Selling
SYRE71.36%28.64%Net SellingNet Selling
VERA66.93%33.07%Net BuyingNet Selling
TARS73.40%26.60%Net SellingNet Selling
View Top Biotech Stocks

Adaptive Biotechnologies Stock Ownership FAQ

Who owns Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ: ADPT) is owned by 95.27% institutional shareholders, 57.77% Adaptive Biotechnologies insiders, and 0.00% retail investors. Viking Global Performance LLC is the largest individual Adaptive Biotechnologies shareholder, owning 30.99M shares representing 20.30% of the company. Viking Global Performance LLC's Adaptive Biotechnologies shares are currently valued at $510.47M.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.